# The Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Affected Dentine

> **NCT04303767** · PHASE2 · UNKNOWN · sponsor: **Hams Hamed Abdelrahman** · enrollment: 132 (estimated)

## Conditions studied

- Caries,Dental

## Interventions

- **DRUG:** Casein phosphopeptide amorphous calcium phosphate
- **PROCEDURE:** Atraumatic restorative treatment

## Key facts

- **NCT ID:** NCT04303767
- **Lead sponsor:** Hams Hamed Abdelrahman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303767, "The Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Affected Dentine". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04303767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*